Belimumab 120mg powder for solution for infusion vials
- SNOMED code
19482011000001103- Active compound
- Belimumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Belimumab
— 120 mg
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Benlysta 120mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd)
in short Benlysta 120mg pdr for concentrate for inf vials
Benlysta 120mg powder for concentrate for solution for infusion vials
- SNOMED code
19480611000001109- Supplier
- GlaxoSmithKline UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Benlysta 120mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial19480711000001100 ref. pack | 💯 Available Legal category: POM | 5000123113859End: 5000123114948End: 050542900028295054290010732 | NHS Indicative Price £121.50 | • Personally Administered • Hospital |
| — |
Reference packs
Belimumab 120mg powder for solution for infusion vials 1 vial
- SNOMED code
19480511000001105- Quantity and unit
- 1 vial
- Packs